• Investing
  • Stock
  • Economy
  • Editor’s Pick
Portfolio Performance Today
Investing

2 Canadian marijuana stocks to keep a close eye on

by February 5, 2022
by February 5, 2022

Marijuana stocks in Canada continue to tumble as fierce competition prevents the big brands on U.S exchanges from capturing a larger share of the Canadian market. So, which Canadian marijuana stocks should investors keep a close eye on?

Tilray stock

Source – TradingView

Tilray Brands, Inc. (NASDAQ:TLRY) stock increased by roughly 14% following its most recent quarterly report. However, it later relinquished those gains. 

From the quarterly report, the company broke even on a per-share basis, although sales fell short of forecasts and estimates from various analysts. In addition, following a drop in the business’s stock price, the company recognized a change in the value of convertible debt and warrants, which boosted non-operating income.

Last year, Tilray and Aphria merged. The company also owns a hemp granola manufacturer, a craft brewer, and a distiller, with the intention of selling THC cannabis products through at least some of those businesses whenever federal legalization is achieved in the United States. It also has an agreement in place to give it a stake in MedMen, a troubled cannabis retailer.

Although some marijuana stock analysts have questioned Tilray’s strategy and mode of operation. The stock has a 19-point Composite Rating and a 48-point Earnings per share (EPS) Rating.

Canopy Growth stock

Source – TradingView

Canopy Growth Corporation (NYSE:CGC) most recent quarterly earnings disappointed investors, continuing the company’s record of disappointing financials. Canopy has pushed back its profit projections, blaming more potent strains in Canada and a delayed distribution rollout in the United States. The company’s executive staff has also been reshuffled.

Canopy operates a CBD business in the United States, with brands like Martha Stewart’s. It has agreements in place to buy Acreage Holdings, a cannabis operator in the United States, and Wana Brands, an edibles manufacturer in the United States, in the near future.

Amongst many marijuana stock analysts, the stock of Canopy Growth has a Composite Rating of 24 and Earnings per share (EPS) Rating of 56. This is quite a good rating.

The post 2 Canadian marijuana stocks to keep a close eye on appeared first on Invezz.

0 comment
0
FacebookTwitterPinterestEmail

previous post
Unity Software stock skyrockets as 2022 revenue forecasts tops estimates
next post
Is PayPal stock a buy after fourth-quarter earnings?

Related Posts

Jim Cramer: a ‘powerful bear market rally’ is...

May 20, 2022

Deere down 15% despite strong results: ‘I like...

May 20, 2022

Twitter stock won’t ‘fall a whole lot’ if...

May 20, 2022

Jablonski is bullish on Amazon: ‘a lot of...

May 20, 2022

Alibaba stock price outlook: Why BABA is a...

May 20, 2022

Deckers Outdoor opened 20% up on Friday: what...

May 20, 2022

Palo Alto Q3 results: ‘getting more interest from...

May 20, 2022

Expert opinion: JPMorgan stock down 30% isn’t ‘that...

May 19, 2022

S&P 500 falls again as bears push stocks...

May 19, 2022

Ross Stores shares tank 25% on Q1 results

May 19, 2022

Recent Posts

  • Jim Cramer: a ‘powerful bear market rally’ is coming

    May 20, 2022
  • Deere down 15% despite strong results: ‘I like it for long-term’

    May 20, 2022
  • Twitter stock won’t ‘fall a whole lot’ if Musk walks away

    May 20, 2022
  • Jablonski is bullish on Amazon: ‘a lot of the issues are resolvable’

    May 20, 2022
  • Alibaba stock price outlook: Why BABA is a bargain

    May 20, 2022
  • Superstitious Storytellers

    May 20, 2022

Editors’ Picks

  • 1

    2 Canadian marijuana stocks to keep a close eye on

    February 5, 2022
  • 2

    Nvidia Corporation earnings beat not sufficient to boost stock – Is it a good buy?

    February 18, 2022
  • 3

    The IMF Should Be Eliminated, Not Expanded

    October 12, 2021
  • 4

    Micron Technology shares are trading lower after-hours: here’s why

    September 29, 2021
  • 5

    Here’s what inflation might look like in 2022

    November 23, 2021
  • 6

    Is Clorox stock a good buy ahead of its fiscal Q1 2022 results?

    October 30, 2021
  • 7

    Vaccine Authoritarianism Explained

    November 6, 2021
Enter Your Information Below To Receive Free Trading Ideas, Latest News, And Articles.


Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

Categories

  • Economy (812)
  • Editor's Pick (310)
  • Investing (2,501)
  • Stock (10)
About Us Terms & Conditions Privacy Policy Email WhiteListing Contact Us

Disclaimer: Portfolioperformancetoday.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2022 Portfolioperformancetoday.com All Rights Reserved.

Portfolio Performance Today
  • Investing
  • Stock
  • Economy
  • Editor’s Pick
Portfolio Performance Today
  • Investing
  • Stock
  • Economy
  • Editor’s Pick

Read alsox

This Tesla rival slid 10% after-hours on...

February 28, 2022

Deltacron: a new COVID variant or just...

January 10, 2022

Top 3 retail stocks to buy in...

January 5, 2022